Same case as mdr id: 2134265-2018-03978.It was reported at an academic conference (b)(4), that in-stent restenosis, myocardial infarction, cerebral infarction, and heart failure occurred.The aim of this study was to investigate the initial clinical results of synergy relative to the non-bsc stent.Percutaneous coronary intervention was performed to 609 lesions from (b)(6) 2015 to (b)(6) 2016.513 lesions which were received synergy stents were subject to this study.The primary end point was in-stent restenosis at follow-up angiography.The secondary end point was the incidence of adverse events including acute myocardial infarction, heart failure and cerebral infarction.In-stent restenosis rate of synergy was significantly increased than that of the non-bsc stent.On (b)(4) method, the patency rate of synergy was significantly decreased compared with that of non-bsc stent ((b)(4); x2=15.58: p<0.001).The incident rate of adverse events for one year was almost same in the two groups.
|